This is filed to report the chordal damage and worsened mitral regurgitation (mr).It was reported that the initial mitraclip procedure was performed in (b)(6) 2018 to treat a mr with a grade of 4.One mitraclip (71027u113) was implanted, reducing the mr to 1.Earlier in the month of (b)(6), the patient presented with worsening heart failure symptoms with increase mr with a grade 3+.The clip was securely attached; however, a flail was noted due to a chordal rupture lateral to the initial clip.The patient remained hospitalized.On (b)(6) 2018, a second mitraclip procedure was performed in an attempt to treat the flail.The clip delivery system (cds 80103u269) was advanced to the mitral valve, but grasping was difficult due to the patient anatomy and image quality.During grasping, an additional chordal damage occurred.The clip was then implanted successfully medial to the first clip.An atrial septal occluder (aso) was attempted to plug the lateral commissure, but was unsuccessful and resulted in additional chordal damage.The mr increased to 4+.It is unknown what the next steps of therapy will be at this time.No additional information was provided.
|
(b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Additionally, a review of the complaint history did not indicate a lot-specific quality issue.All available information was investigated and the reported failure to bond (difficulty grasping the leaflets) and poor image resolution appears to be a combination of the challenging patient morphology/pathology (flail posterior leaflet) and procedural circumstances (visualization).The reported mitral valve injury (tissue damage) appears to be a cascading effect of the difficulty grasping the leaflets.The reported recurrent mitral regurgitation (mr) appears to be a result of procedural conditions/cascading effect of the mitral valve injury.The reported patient effects of worsening mr and tissue damage as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.There is no indication of a product quality issue with respect to design, manufacturing, or labeling of the device.
|